The aim of the study was to prepare the controlled release dosage of carbamazepine matrix tablets using wet granulation technique. The graft copolymerization of carboxymethyl chitosan (CMCH) with 2-hydroxyethylmethacrylate (HEMA) was carried out. The product was characterized by Fourier-transform infrared, scanning electron microscopy, transmission electron micrograph, and X-ray diffraction anayses. CMCH-g-HEMA was used as binder to prepare the matrix tablets containing carbamazepine. The properties of tablets like hardness, friability, and dissolution influenced by binder were studied. In vitro release of the matrix tablets was carried out with the phosphate-buffered solution (pH 7.4) at 37°C and 100 × g using USP dissolution test apparatus. Release rate of carbamazepine from controlled release matrix tablets was compared with the commercially marketed tablet, Tagretol 200. Results show that after 6 hrs percentage drug release of formulated tablet CGH5 was 20.42% and that of Tegretol 200 was 18.32%. © 2009 Wiley Periodicals, Inc. J Appl Polym Sci, 2010
If you can't find a tool you're looking for, please click the link at the top of the page to "Go to old article view". Alternatively, view our Knowledge Base articles for additional help. Your feedback is important to us, so please let us know if you have comments or ideas for improvement.